ArticleJournal for immunotherapy of cancer2025
Correction: Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.